Linzess

Chemical Namelinaclotide
Dosage FormCapsules (oral; 72 mcg, 145mcg, 290 mcg)
Drug ClassReceptor agonists
SystemDigestive
CompanyAllergan
Approval Year2012

Indication

  • For the treatment of irritable bowel syndrome with constipation (IBS-C) in adults.
  • For the treatment of chronic idiopathic constipation in adults.
Last updated on 5/11/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Linzess (linaclotide) Prescribing Information2012Allergan USA Inc., Irvine, CA